Eli Lilly and Company (LLY)
Eli Lilly (LLY) Q2 Earnings and Revenues Surpass Estimates
Eli Lilly (LLY) came out with quarterly earnings of $8.38 per share, beating the Zacks Consensus Estimate of $6.01 per share. This compares to earnings of $6.31 per share a year ago.
Here's How Much Traders See Eli Lilly Stock Moving After Earnings
Eli Lilly is scheduled to report earnings Wednesday morning, with traders expecting the drugmaker's stock could potentially approach last month's highs following the results.
Novo Nordisk vs Eli Lilly: The Better Buy Before Earnings
Novo Nordisk (NYSE: NVO | NVO Price Prediction) and Eli Lilly (NYSE: LLY) both posted Q1 FY2026 results this spring, and the gap between them keeps widening.
Novo Nordisk Wipes Out $30 Billion In Market Value After Failed Heart Drug Trial
$30.7 billion. That's how much was cut from Novo Nordisk's market capitalization as of Friday's share price, lowering from $229.2 billion to $198.5 billion, marking a nearly 69% decline since hitting an all-time high of $635.7 billion in June 2024.
Lilly (LLY) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Lilly (LLY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The Week Ahead: Jobs Data, Top 10 Earnings Reports to Watch
Next week keeps up the earnings barrage, a heavy dose of earnings from some of the market's largest companies, led by pharma giant Eli Lilly (LLY) and industrial bellwether Caterpillar (CAT).
Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy?
Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eli Lilly (LLY) Rises Higher Than Market: Key Facts
Eli Lilly (LLY) closed the most recent trading day at $1, moving +2.09% from the previous trading session.
This Catalyst Makes Eli Lilly a Top Growth Stock in 2026
Eli Lilly (NYSE:LLY | LLY Price Prediction) has accelerated despite its $1 trillion scale.
LLY's Retatrutide Nears 2027 Filing With Two More Phase III Wins
Eli Lilly's retatrutide meets the primary endpoint in the phase III TRIUMPH-2 & TRIUMPH-3 studies, supporting planned regulatory submissions for obesity in 2027.
As Lilly and Novo Clash in Court, Wall Street Is Eyeing This Bigger Prize
The legal battle between Novo Nordisk and Eli Lilly is escalating, but analysts are more focused on developments in the lab.
